Paul Stamets Psilocybin Mushrooms and The Mycology of Consciousness
01:07:43 min
CLEAR ALL
The first randomized controlled trial to compare the illicit psychedelic psilocybin with a conventional selective serotonin reuptake inhibitor (SSRI) antidepressant found that the former improved symptoms of depression just as well on an established metric—and had fewer side effects.
1
When Michael Pollan set out to research how LSD and psilocybin (the active ingredient in magic mushrooms) are being used to provide relief to people suffering from difficult-to-treat conditions such as depression, addiction, and anxiety, he did not intend to write what is undoubtedly his most...
6
Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.
Amazonian healing traditions collide with Western medical sensibilities.
2
A new generation of research into psilocybin could change how we treat numerous mental health conditions.
In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.
At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.
The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.
My first encounter with ketamine did not go well.
The most comprehensive and approachable book available on understanding and using medical marijuana.